1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with erucyl amide in 1 studies
| Studies (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Trials (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Recent Studies (post-2010) (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Studies (erucyl amide) | Trials (erucyl amide) | Recent Studies (post-2010) (erucyl amide) |
|---|---|---|---|---|---|
| 9,156 | 187 | 552 | 25 | 0 | 13 |
| Protein | Taxonomy | 1-hexadecyl-2-acetyl-glycero-3-phosphocholine (IC50) | erucyl amide (IC50) |
|---|---|---|---|
| Transient receptor potential cation channel subfamily V member 2 | Rattus norvegicus (Norway rat) | 3.885 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Deng, L; Geng, Y; Li, T; Lü, J; Ma, Y; Sun, F; Wang, C | 1 |
1 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and erucyl amide
| Article | Year |
|---|---|
[Serum metabolomics analysis on benign prostate hyperplasia in mice based on liquid chromatography-mass spectrometry].
Topics: Animals; Biomarkers; Chromatography, High Pressure Liquid; Discriminant Analysis; Disease Models, Animal; Erucic Acids; Humans; Hyperplasia; Male; Mass Spectrometry; Metabolomics; Mice; Platelet Activating Factor; Prostate; Serum | 2014 |